Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

被引：104
|
作者：
Choo, Eun Ju [1 ]
Chambers, Henry F. [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Dept Med, Div Infect Dis, Bucheon, South Korea
[2] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA
来源：
INFECTION AND CHEMOTHERAPY | 2016年 / 48卷 / 04期
关键词：
Methicillin-resistant Staphylcoccus aureus; Vancomycin; Treatment;
D O I：
10.3947/ic.2016.48.4.267
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
引用
收藏
页码：267 / 273
页数：7
相关论文
共 50 条
  • [1] Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
    Usery, Justin B.
    Vo, Ngan H.
    Finch, Christopher K.
    Cleveland, Kerry O.
    Gelfand, Michael S.
    Self, Timothy H.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (01): : 36 - 41
  • [2] Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia
    White, Bryin Pinckney
    Barber, Katie E.
    Stover, Kayla R.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (04) : 201 - 208
  • [3] METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS BACTEREMIA
    MCDONALD, M
    HURSE, A
    SIM, KN
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1981, 2 (04) : 191 - 194
  • [4] Management of methicillin-resistant Staphylococcus aureus bacteremia
    Cosgrove, Sara E.
    Fowler, Vance G., Jr.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S386 - S393
  • [5] Methicillin-Resistant Staphylococcus aureus Bacteremia and Pneumonia
    Ganesan, Anuradha
    [J]. DM DISEASE-A-MONTH, 2008, 54 (12): : 787 - 792
  • [6] Methicillin-resistant/methicillin-sensitive Staphylococcus aureus bacteremia
    Austin, TW
    Austin, MA
    Coleman, B
    [J]. SAUDI MEDICAL JOURNAL, 2003, 24 (03) : 256 - 260
  • [7] Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment
    Parsons, Joshua. B.
    Westgeest, Annette. C.
    Conlon, Brian. P. B.
    Fowler, Vance. G., Jr.
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (03):
  • [8] Escalated Daptomycin Doses for Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia
    Wu, Gary
    Jeng, Franklin
    Abraham, Teena
    Yuen, Meggie
    Goldshteyn, Natalya
    Colby, Steven
    Andrescavage, Roseanni
    Nauffal, Mary
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [9] Shock as a covariate in a study of treatment of methicillin-resistant Staphylococcus aureus bacteremia
    Lustberg, Mark E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (09) : 1483 - 1483
  • [10] Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia
    Mangili, A
    Bica, I
    Snydman, DR
    Hamera, DH
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (07) : 1058 - 1060
12345